MicroRNAs: Potential Biomarkers and Therapeutic Targets for Alveolar Bone Loss in Periodontal Disease

Int J Mol Sci. 2016 Aug 11;17(8):1317. doi: 10.3390/ijms17081317.

Abstract

Periodontal disease is an inflammatory disease caused by bacterial infection of tooth-supporting structures, which results in the destruction of alveolar bone. Osteoclasts play a central role in bone destruction. Osteoclasts are tartrate-resistant acid phosphatase (TRAP)-positive multinucleated giant cells derived from hematopoietic stem cells. Recently, we and other researchers revealed that microRNAs are involved in osteoclast differentiation. MicroRNAs are novel, single-stranded, non-coding, small (20-22 nucleotides) RNAs that act in a sequence-specific manner to regulate gene expression at the post-transcriptional level through cleavage or translational repression of their target mRNAs. They regulate various biological activities such as cellular differentiation, apoptosis, cancer development, and inflammatory responses. In this review, the roles of microRNAs in osteoclast differentiation and function during alveolar bone destruction in periodontal disease are described.

Keywords: alveolar bone loss; exosomes; extracellular vesicles; microRNAs; osteoclasts; periodontal disease.

Publication types

  • Review

MeSH terms

  • Alveolar Bone Loss / genetics
  • Alveolar Bone Loss / metabolism*
  • Alveolar Bone Loss / pathology
  • Biomarkers / metabolism*
  • Humans
  • MicroRNAs / genetics*
  • Periodontal Diseases / genetics
  • Periodontal Diseases / metabolism*
  • Periodontal Diseases / pathology

Substances

  • Biomarkers
  • MicroRNAs